ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2280

Monosodium Urate Crystal-Induced Inflammation Promotes Osteocyte Expression of Pro-Resorptive and Inflammatory Mediators: Implications for Erosive Gout

Ashika Chhana1, Mei-Lin Tay2, Bregina Pool3, Karen E. Callon2, David Musson2, Dorit Naot1, Gregory Gamble3, Jillian Cornish3 and Nicola Dalbeth2, 1Medicine, University of Auckland, Auckland, New Zealand, 2University of Auckland, Auckland, New Zealand, 3Department of Medicine, University of Auckland, Auckland, New Zealand

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Bone, gout, inflammation and osteocytes

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Metabolic and Crystal Arthropathies - Poster II: Epidemiology and Mechanisms of Disease

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:   Bone erosion in gout is strongly associated with tophi; lesions comprising of inflammatory cells surrounding collections of monosodium urate (MSU) crystals.  Osteocytes are the most abundant cell population within bone and are important regulators of bone remodeling.  The aim of this study was to investigate the direct effects of MSU crystals and indirect effects of MSU crystal-induced inflammation on osteocyte function.

Methods:   For direct in vitro assays, MSU crystals were added to MLO-Y4 osteocyte-like cells cultured in type I collagen gels (3D) for 1h, 6h and 24h.  For indirect in vitro assays, RAW264.7 macrophage-like cells were cultured with or without MSU crystals (0.5mg/mL) for 24h and supernatants were harvested and filtered for conditioned media preparation.  The conditioned media (40%) was then added to the 3D MLO-Y4 cultures for 1h, 6h and 24h. All changes in MLO-Y4 gene expression were examined using real-time PCR and analyzed using two-way ANOVA with post hoc Sidak’s tests.  The relationship between osteocytes, MSU crystals and macrophages in erosive gout was examined by polarizing light microscopy and CD68 immunohistochemistry in joint samples obtained from cadaveric donors with crystal-proven gout.

Results:   In the direct in vitro assays, culture with MSU crystals alone did not alter the expression of osteocyte-related genes or inflammatory mediator gene expression (P>0.1 for all).  In contrast, addition of conditioned media from MSU crystal-exposed RAW264.7 cells to MLO-Y4 cultures led to a ~2-4-fold increase in expression of E11 and connexin43 at the 6h and 24h time-points compared to control conditioned media (P<0.0001).  RANKL expression was also increased at 6h and 24h (P<0001, Figure) and OPG expression was reduced at the 6h time-point by ~2-fold (P=0.007).  In addition, expression of inflammatory genes was upregulated, including TNF-a (~4-fold at 1h), IL-1b (~5-fold at 6h and 24h), IL-8 (>500-fold at all time-points), IL-11 (>200-fold at 6h and 24h), IL-6 and cyclooxygenase-2 (Figure) (P≤0.001 for all).  In histological analysis of cadaveric joint samples affected by gout, numerous CD68+ macrophages and MSU crystals were identified in proximity to osteocytes within bone.            

Conclusion: MSU crystals do not directly influence osteocyte-related gene expression.  However, interactions between MSU crystals and immune cells in the joint may promote osteocyte expression of pro-resorptive and inflammatory mediators, which can have important consequences for local bone remodeling.  These indirect effects on osteocyte function may contribute to bone erosion in gout.

Figure: Mean (SEM) changes in relative expression levels of RANKL, COX-2 and IL-6 in MLO-Y4 cells cultured with 40% conditioned media from MSU crystal-exposed RAW264.7 cells or control RAW264.7 cells (no MSU). Post hoc Sidak’s test, *p<0.05, **p<0.01 and ***p<0.001 vs control conditioned media.

 


Disclosure: A. Chhana, None; M. L. Tay, None; B. Pool, None; K. E. Callon, None; D. Musson, None; D. Naot, None; G. Gamble, None; J. Cornish, None; N. Dalbeth, None.

To cite this abstract in AMA style:

Chhana A, Tay ML, Pool B, Callon KE, Musson D, Naot D, Gamble G, Cornish J, Dalbeth N. Monosodium Urate Crystal-Induced Inflammation Promotes Osteocyte Expression of Pro-Resorptive and Inflammatory Mediators: Implications for Erosive Gout [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/monosodium-urate-crystal-induced-inflammation-promotes-osteocyte-expression-of-pro-resorptive-and-inflammatory-mediators-implications-for-erosive-gout/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/monosodium-urate-crystal-induced-inflammation-promotes-osteocyte-expression-of-pro-resorptive-and-inflammatory-mediators-implications-for-erosive-gout/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology